2-methyl-3-(4-phenylpiperidino)propionohydroxamic acid hydrochloride--a new hypotensive agent.
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects*; D002340:Carotid Artery Diseases; D002415:Cats; D004357:Drug Synergism; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D005725:Ganglia, Autonomic / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects*; D006877:Hydroxamic Acids / Q000008:administration & dosage / Q000494:pharmacology*; D007082:Ileum / Q000187:drug effects; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D009538:Nicotine / Q000037:antagonists & inhibitors; D009541:Nictitating Membrane / Q000187:drug effects; D010425:Pentolinium Tartrate / Q000494:pharmacology; D010880:Piperidines / Q000008:administration & dosage / Q000494:pharmacology*; D011422:Propionates / Q000008:administration & dosage / Q000494:pharmacology*
D006877:Hydroxamic Acids; D010880:Piperidines; D011422:Propionates; D009538:Nicotine; D001285:Atropine; D010425:Pentolinium Tartrate; D000109:Acetylcholine; D004837:Epinephrine